Riskpilot← Back to searchSign inGet full accessMatilda Larson Naprapatforum AB
ABActiveOrg 5569513061Marmorgatan 15Physiotherapy activities · NACE 8695Est. 20131-4 employees
Revenue 2024
SEK 2,8M
0% vs 2023
EBITDA margin
0.1%
-99% vs 2023
Equity ratio
50.9%
Financial strength
Net profit 2024
SEK -13K
-110% vs 2023
| Revenue | SEK 2,8M | +0% |
| EBITDA | SEK 3K | -99% |
| Net profit | SEK -13K | -110% |
| Total assets | SEK 662K | -17% |
| Equity | SEK 337K | -4% |
| Employees | — | — |
Legal name
Matilda Larson Naprapatforum AB
Org number
5569513061
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
2 december 2013
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva naprapat- och friskvårdsverksamhet samt därmed förenlig verksamhet. Aktiebolaget ska även kunna äga och förvalta fast och lös egendom samt bedriva därmed förenlig verksamhet.
Address
Marmorgatan 15
Phone
+46313527070
Email
larson.matilda@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 924 | 1 487 | 1 955 | 2 797 | 2 791 |
| Staff expenses | — | — | −1 316 | −1 976 | −2 113 |
| EBITDA | 248 | 165 | 43 | 217 | 3 |
| Depreciation & amort. | −104 | −110 | −110 | −57 | −20 |
| EBIT | 144 | 55 | −67 | 160 | −17 |
| Net financials | — | — | 0 | 2 | 3 |
| Profit before tax | 144 | 55 | −67 | 162 | −13 |
| Tax | −19 | −12 | — | −30 | — |
| Net profit | 125 | 43 | −67 | 132 | −13 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 101 | 542 | 532 | 800 | 662 |
| Equity | 241 | 285 | 218 | 350 | 337 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 700 | 98 | 155 | 267 | 325 |
| Total debt | 700 | 98 | 155 | 267 | 325 |
EBITDA margin
0.1%
This company
15.8%
Market median
-99% vs market
20202024
Equity ratio
50.9%
This company
38.2%
Market median
+33% vs market
20202024
Return on equity
-4.0%
This company
18.4%
Market median
-122% vs market
20202024
Net profit margin
-0.5%
This company
8.1%
Market median
-106% vs market
20202024
Asset turnover
4.22×
This company
1.12×
Market median
+277% vs market
20202024
Debt / equity
0.97×
This company
0.62×
Market median
+56% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Matilda Larson Naprapatforum AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristján Fannar Sigurðarson | Deputy Board Member | 0 companies |
| Elin Matilda Larson | Board of Directors | 0 companies |
| Siv Margareta Leander Larson | Deputy Board Member | 0 companies |